Investigational Site Number 036003

Randwick 2031

0 studies enrolling now · 2 studies all time

What they study most

Hematopoietic Neoplasm

Studies at this site

• Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia — Completed
• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed